These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29359149)

  • 1. Isolation of Potential Phages against Multidrug-Resistant Bacterial Isolates: Promising Agents in the Rivers of Kathmandu, Nepal.
    Bhetwal A; Maharjan A; Shakya S; Satyal D; Ghimire S; Khanal PR; Parajuli NP
    Biomed Res Int; 2017; 2017():3723254. PubMed ID: 29359149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal.
    Nepal K; Pant ND; Neupane B; Belbase A; Baidhya R; Shrestha RK; Lekhak B; Bhatta DR; Jha B
    Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):62. PubMed ID: 28927454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and Characterization of Lytic Bacteriophage Against Multi-drug Resistant Pseudomonas aeruginosa.
    Maharjan A; Nepal R; Dhungana G; Parajuli A; Regmi M; Upadhyaya E; Mandal D; Shrestha M; Pradhan P; Manandhar KD; Malla R
    J Nepal Health Res Counc; 2022 Mar; 19(4):717-724. PubMed ID: 35615828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections.
    Pallavali RR; Degati VL; Lomada D; Reddy MC; Durbaka VRP
    PLoS One; 2017; 12(7):e0179245. PubMed ID: 28719657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic characterization of three bacteriophages targeting multidrug resistant clinical isolates of Escherichia, Klebsiella and Salmonella.
    Nepal R; Houtak G; Karki S; Dhungana G; Vreugde S; Malla R
    Arch Microbiol; 2022 May; 204(6):334. PubMed ID: 35585249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
    Manohar P; Nachimuthu R; Lopes BS
    BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of lytic bacteriophages from various sources in Addis Ababa against antimicrobial-resistant diarrheagenic Escherichia coli strains and evaluation of their therapeutic potential.
    Sada TS; Tessema TS
    BMC Infect Dis; 2024 Mar; 24(1):310. PubMed ID: 38486152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophages as therapeutic & disinfectant agents to tackle multidrug-resistant
    Rathor N; Bahadur T; Thakur CK; Bamola VD; Das BK; Chaudhry R
    Indian J Med Res; 2023 Jun; 157(6):549-558. PubMed ID: 37530310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia.
    Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Tao D; Ding L; Reed E; Gong J; Li QQ; Hu J
    Int J Mol Med; 2006 Feb; 17(2):347-55. PubMed ID: 16391836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-Demand Isolation of Bacteriophages Against Drug-Resistant Bacteria for Personalized Phage Therapy.
    Mattila S; Ruotsalainen P; Jalasvuori M
    Front Microbiol; 2015; 6():1271. PubMed ID: 26617601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended spectrum beta-lactamase producing multidrug resistant urinary isolates from children visiting Kathmandu Model Hospital.
    Dhakal S; Manandhar S; Shrestha B; Dhakal R; Pudasaini M
    Nepal Med Coll J; 2012 Jun; 14(2):136-41. PubMed ID: 23671965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterisation of lytic bacteriophages of Klebsiella pneumoniae and Klebsiella oxytoca.
    Karumidze N; Kusradze Ia; Rigvava S; Goderdzishvili M; Rajakumar K; Alavidze Z
    Curr Microbiol; 2013 Mar; 66(3):251-8. PubMed ID: 23143289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abundance in sewage of bacteriophages infecting Escherichia coli O157:H7.
    Muniesa M; Jofre J
    Methods Mol Biol; 2004; 268():79-88. PubMed ID: 15156020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three novel Enterobacter cloacae bacteriophages for therapeutic use from Ghanaian natural waters.
    Lyytinen OL; Dapuliga C; Wallinger D; Patpatia S; Audu BJ; Kiljunen SJ
    Arch Virol; 2024 Jul; 169(8):156. PubMed ID: 38967872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophages isolated from Lake Michigan demonstrate broad host-range across several bacterial phyla.
    Malki K; Kula A; Bruder K; Sible E; Hatzopoulos T; Steidel S; Watkins SC; Putonti C
    Virol J; 2015 Oct; 12():164. PubMed ID: 26453042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective Phages as Green Antimicrobial Agents Against Antibiotic-Resistant Hospital Escherichia coli.
    Rahmani R; Zarrini G; Sheikhzadeh F; Aghamohammadzadeh N
    Jundishapur J Microbiol; 2015 Feb; 8(2):e17744. PubMed ID: 25834712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended spectrum â-lactamase producing multidrug resistant clinical bacterial isolates at National Public Health Laboratory, Nepal.
    Poudyal S; Bhatta DR; Shakya G; Upadhyaya B; Dumre SP; Buda G; Kandel BP
    Nepal Med Coll J; 2011 Mar; 13(1):34-8. PubMed ID: 21991699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Phage cocktail against infantile Sepsis bacteria.
    Gatea Kaabi SA; Musafer HK
    Microb Pathog; 2020 Nov; 148():104447. PubMed ID: 32805360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic method to isolate large bacteriophages for use in biocontrol of a wide-range of pathogenic bacteria.
    Saad AM; Soliman AM; Kawasaki T; Fujie M; Nariya H; Shimamoto T; Yamada T
    J Biosci Bioeng; 2019 Jan; 127(1):73-78. PubMed ID: 30049605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of polyvalent bacteriophages specific to uropathogenic Proteus mirabilis strains based on the host range pattern and RFLP.
    Maszewska A; Wójcik E; Ciurzyńska A; Wojtasik A; Piątkowska I; Dastych J; Różalski A
    Acta Biochim Pol; 2016; 63(2):303-10. PubMed ID: 26730411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.